Safety Shot, Inc. announces private investment of $1.29 million

Safety Shot, Inc. (NASDAQ:SHOT), a company specializing in personal care products with a current market capitalization of $34.16 million, has entered into a Securities Purchase Agreement with an accredited investor for a private investment in public equity (PIPE) deal. The agreement, executed on March 13, 2025, entails the sale of 3.5 million shares at a price of $0.368 per share, resulting in gross proceeds of approximately $1.29 million. According to InvestingPro analysis, the stock currently appears undervalued compared to its Fair Value.

The transaction provides the investor with shares of common stock in the company, which is known for its range of perfumes, cosmetics, and other personal care items. The shares involved in the deal are referred to as PIPE Shares. InvestingPro data shows the company maintains a healthy current ratio of 1.9, indicating sufficient liquidity to meet short-term obligations, though its overall financial health score is currently rated as Weak.

Safety Shot, Inc., formerly known as Jupiter Wellness, Inc. and CBD Brands, Inc., is headquartered in Jupiter, Florida. The company’s securities, including common stock and warrants, are traded on The Nasdaq Capital Market under the symbols SHOT and SHOTW, respectively. The stock, currently trading at $0.50, has shown significant volatility, with analysts projecting substantial revenue growth of 189% for the current fiscal year.

The PIPE transaction is a strategic move by Safety Shot, Inc. to raise capital from an accredited investor, which may be used to fund its operational activities, research and development, or other corporate purposes. The details of the Securities Purchase Agreement are outlined in the Form 8-K filed with the SEC, reflecting the company’s commitment to transparency and regulatory compliance. For deeper insights into Safety Shot’s financial health and growth prospects, investors can access comprehensive analysis and 15+ additional ProTips through InvestingPro’s detailed research reports.

Investors and stakeholders can access the full text of the Securities Purchase Agreement as part of the company’s SEC filings. This deal signifies an important financial development for Safety Shot, Inc., as it continues to navigate the competitive personal care industry.

This news article is based on a press release statement from Safety Shot, Inc. and presents the facts without analysis or commentary. The information provided is intended to give readers a clear and concise understanding of the company’s recent financial activity.

In other recent news, Safety Shot, Inc. has reported promising results from a clinical trial of its dietary supplement, Safety Shot®, which appears to reduce the effects of alcohol consumption. The study, published in the Journal of Nutrition and Dietary Supplements, shows that the supplement can significantly lower blood and breath alcohol concentrations and alleviate hangover symptoms. Safety Shot, Inc. also announced a $1 million funding boost through a Securities Purchase Agreement with an accredited investor, indicating confidence in the company’s growth potential. The funds are expected to support ongoing operations, research, and expansion plans. Meanwhile, Scandic Hotels Group has reported strong financial results for Q4 2024, with adjusted EBITDA increasing to SEK 544 million from SEK 451 million the previous year. The company also announced a strategic partnership with SAS and plans for tech upgrades. Additionally, Scandic Hotels is launching a share buyback program and has proposed an ordinary dividend, reflecting its solid financial health and positive market momentum.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.